BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32229754)

  • 1. Olanzapine for the Prevention of Postdischarge Nausea and Vomiting after Ambulatory Surgery: A Randomized Controlled Trial.
    Hyman JB; Park C; Lin HM; Cole B; Rosen L; Fenske SS; Barr Grzesh RL; Blank SV; Polsky SB; Hartnett M; Taub PJ; Palvia V; DeMaria S; Ascher-Walsh C
    Anesthesiology; 2020 Jun; 132(6):1419-1428. PubMed ID: 32229754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled study evaluating the efficacy of combination olanzapine, ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving doxorubicin plus cyclophosphamide.
    Tienchaiananda P; Nipondhkit W; Maneenil K; Sa-Nguansai S; Payapwattanawong S; Laohavinij S; Maneechavakajorn J
    Ann Palliat Med; 2019 Sep; 8(4):372-380. PubMed ID: 31500422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiemetic prophylaxis for postdischarge nausea and vomiting and impact on functional quality of living during recovery in patients with high emetic risks: a prospective, randomized, double-blind comparison of two prophylactic antiemetic regimens.
    Pan PH; Lee SC; Harris LC
    Anesth Analg; 2008 Aug; 107(2):429-38. PubMed ID: 18633020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ondansetron and dolasetron provide equivalent postoperative vomiting control after ambulatory tonsillectomy in dexamethasone-pretreated children.
    Sukhani R; Pappas AL; Lurie J; Hotaling AJ; Park A; Fluder E
    Anesth Analg; 2002 Nov; 95(5):1230-5, table of contents. PubMed ID: 12401599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Hashimoto H; Abe M; Tokuyama O; Mizutani H; Uchitomi Y; Yamaguchi T; Hoshina Y; Sakata Y; Takahashi TY; Nakashima K; Nakao M; Takei D; Zenda S; Mizukami K; Iwasa S; Sakurai M; Yamamoto N; Ohe Y
    Lancet Oncol; 2020 Feb; 21(2):242-249. PubMed ID: 31838011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevention of emesis in plastic surgery: a randomized, prospective study.
    Marcus JR; Few JW; Chao JD; Fine NA; Mustoe TA
    Plast Reconstr Surg; 2002 Jun; 109(7):2487-94. PubMed ID: 12045581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine for the prevention of postoperative nausea and vomiting after gynecologic laparoscopic surgery: a randomized controlled trial.
    Chen N; Ji S; Liu J; Wang L; Chen F; Zhu Y; Li J; Chen M; Chen L; Wang M; He R; Mei X; Zhang Z; Jin S; Zheng J; Jiang Y
    Ther Adv Drug Saf; 2024; 15():20420986241244593. PubMed ID: 38646425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone versus ondansetron in combination with dexamethasone for the prophylaxis of postoperative vomiting in pediatric outpatients: a double-blind, randomized, placebo-controlled clinical trial.
    de Orange FA; Marques J; Flores M; Borges PS
    Paediatr Anaesth; 2012 Sep; 22(9):890-6. PubMed ID: 22731240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of the addition of olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.
    Vimolchalao V; Sakdejayont S; Wongchanapai P; Sukprakun S; Angspatt P; Thawinwisan W; Chenaksara P; Sriuranpong V; Vinayanuwatikun C; Parinyanitikun N; Poovorawan N; Tanasanvimon S
    Int J Clin Oncol; 2020 Feb; 25(2):396-402. PubMed ID: 31776732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palonosetron as prophylaxis for post-discharge nausea and vomiting: a prospective, randomised, double-blind, placebo-controlled trial in ambulatory surgery.
    Moraitis A; Myrberg T; Hultin M; Nyström H; Walldén J
    Br J Anaesth; 2023 Aug; 131(2):276-283. PubMed ID: 37246062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.
    Gan TJ; Sinha AC; Kovac AL; Jones RK; Cohen SA; Battikha JP; Deutsch JS; Pergolizzi JV; ; Glass PS
    Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups.
    Fortney JT; Gan TJ; Graczyk S; Wetchler B; Melson T; Khalil S; McKenzie R; Parrillo S; Glass PS; Moote C; Wermeling D; Parasuraman TV; Duncan B; Creed MR
    Anesth Analg; 1998 Apr; 86(4):731-8. PubMed ID: 9539593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of ramosetron with ondansetron for prevention of postoperative nausea and vomiting in patients undergoing gynaecological surgery.
    Kim SI; Kim SC; Baek YH; Ok SY; Kim SH
    Br J Anaesth; 2009 Oct; 103(4):549-53. PubMed ID: 19700442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fosaprepitant versus ondansetron for the prevention of postoperative nausea and vomiting in patients who undergo gynecologic abdominal surgery with patient-controlled epidural analgesia: a prospective, randomized, double-blind study.
    Soga T; Kume K; Kakuta N; Hamaguchi E; Tsutsumi R; Kawanishi R; Fukuta K; Tanaka K; Tsutsumi YM
    J Anesth; 2015 Oct; 29(5):696-701. PubMed ID: 25801542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ondansetron versus placebo for prophylaxis of nausea and vomiting in patients undergoing ambulatory laparoscopic cholecystectomy.
    Liberman MA; Howe S; Lane M
    Am J Surg; 2000 Jan; 179(1):60-2. PubMed ID: 10737581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of preoperative ondansetron on the incidence of postoperative nausea and vomiting in patients undergoing outpatient dentoalveolar surgery and general anesthesia.
    Wagley C; Hackett C; Haug RH
    J Oral Maxillofac Surg; 1999 Oct; 57(10):1195-200. PubMed ID: 10513865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blinded comparison of ondansetron, droperidol, and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy.
    Fabling JM; Gan TJ; El-Moalem HE; Warner DS; Borel CO
    Anesth Analg; 2000 Aug; 91(2):358-61. PubMed ID: 10910848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ondansetron/promethazine combination or promethazine alone reduces nausea and vomiting after middle ear surgery.
    Khalil S; Philbrook L; Rabb M; Wells L; Aves T; Villanueva G; Amhan M; Chuang AZ; Lemak NA
    J Clin Anesth; 1999 Nov; 11(7):596-600. PubMed ID: 10624646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine as an add-on, pre-operative anti-emetic drug for postoperative nausea or vomiting: a randomised controlled trial.
    Grigio TR; Timmerman H; Martins JVB; Slullitel A; Wolff AP; Sousa AM
    Anaesthesia; 2023 Oct; 78(10):1206-1214. PubMed ID: 37449978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amisulpride for the Rescue Treatment of Postoperative Nausea or Vomiting in Patients Failing Prophylaxis: A Randomized, Placebo-controlled Phase III Trial.
    Habib AS; Kranke P; Bergese SD; Chung F; Ayad S; Siddiqui N; Motsch J; Leiman DG; Melson TI; Diemunsch P; Fox GM; Candiotti KA
    Anesthesiology; 2019 Feb; 130(2):203-212. PubMed ID: 30475232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.